Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease

PLoS ONE(2024)10.1371/journal.pone.0304644Source: DataRank Database

Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (33)IDs (PubMed, PMC)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Lauren E. Brown ORCID,Sebastian Seiguer,Katie Munshaw,Joseph R. Rausch,Sherif M. Badawy ORCID

Live enrichment

PubMed:38917111 PMC:PMC11198815

National Heart, Lung, and Blood Institute

Grant: 1 R44 HL169085

NHLBI NIH HHS

Grant: R44 HL169085

National Institutes of Health

Grant: 5R44HL169085-02

ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)

goldLicense: cc-by

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0304644&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0304644

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11198815/pdf/pone.0304644.pdf

repositoryhttps://doaj.org/article/48d516af7b784402963d2d4b1d9ddcbb

repositoryhttps://doaj.org/article/e80c114e61df4fcbb8bf52562796f8ac

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansAnemia, Sickle CellHydroxyureaAntisickling AgentsAdolescentAdultChildFemaleMaleMulticenter Studies as TopicRandomized Controlled Trials as TopicMedication AdherenceYoung Adult

Keywords

AdultMaleAdolescentScienceQRAnemia, Sickle CellMedication AdherenceStudy ProtocolYoung AdultAntisickling AgentsMedicineHumansHydroxyureaMulticenter Studies as TopicFemaleChildRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 3: 3. Good healthSDG 8: 8. Economic growthSDG 16: 16. Peace & justice

Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease

FAIR Checklist

Authors (10)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)